First report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia
is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two...
Saved in:
Published in | Emerging microbes & infections Vol. 13; no. 1; p. 2300525 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis Ltd
01.12.2024
Taylor & Francis Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of
candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All
isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the
gene. The isolates with Clade I presented Y132F mutation in the
gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of
candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of
candidemia and colonization after the first positive bloodstream.
colonization was still observed after the first
candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of
in Guangdong, highlighting great challenges in clinical prevention and control. |
---|---|
AbstractList | Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control. is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the gene. The isolates with Clade I presented Y132F mutation in the gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of candidemia and colonization after the first positive bloodstream. colonization was still observed after the first candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of in Guangdong, highlighting great challenges in clinical prevention and control. Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control. Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control. |
Author | Chen, Peisong Guo, Penghao Liu, Yue Yu, Xuegao Fang, Jingchun Guo, Zhaowang Liao, Kang Peng, Yaqin |
Author_xml | – sequence: 1 givenname: Yaqin surname: Peng fullname: Peng, Yaqin organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China – sequence: 2 givenname: Yue surname: Liu fullname: Liu, Yue organization: Department of Clinical Laboratory, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China – sequence: 3 givenname: Xuegao surname: Yu fullname: Yu, Xuegao organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China – sequence: 4 givenname: Jingchun surname: Fang fullname: Fang, Jingchun organization: Department of Clinical Microbiology Laboratory, Nansha Division of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China – sequence: 5 givenname: Zhaowang surname: Guo fullname: Guo, Zhaowang organization: Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, People’s Republic of China – sequence: 6 givenname: Kang surname: Liao fullname: Liao, Kang organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China – sequence: 7 givenname: Peisong surname: Chen fullname: Chen, Peisong organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China – sequence: 8 givenname: Penghao surname: Guo fullname: Guo, Penghao organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38164742$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAQjVARLaU_AWSJCwd2GdtJ7MABVStaKlXiAmfL8UfWq8Re7AQJ8efrZLdV2wvjg8czb57Hnve6OPHBm6J4i2GNgcMnkg2zCq8JELomFKAi1YvibI6v5sTJI_-0uEhpB9kY1CUuXxWnlOO6ZCU5K_5duZhGFM0-xBEFizbSa6clklN0CTmPrifpOx189xFtts7Lz0j1zjsle5ShaHAqhtaFPnRLTG1llGo0uXp0Ks2UDJm9S0Gb5aSWC8zg5JvipZV9MhfH_bz4dfXt5-b76vbH9c3m8nalKqjHFbEMgzW0rW1pGsiO5lrRlhqqVEN5S0C3lHHKQHFODFBMjeWaScCkrVp6XtwceHWQO7GPbpDxrwjSiSUQYidkzM32RtimKZmteIV5U3JGZQkUDG40B2V1XWWurweu_dQORivjxyj7J6RPM95tRRf-CAyM0bqmmeHDkSGG35NJoxhcUqbvpTdhSoI0MC_SlBn6_hl0F6bo818JikuCMaEL4bvHLT30cj_kDKgOgDyplKKxDxAMYtaTuNeTmPUkjnrKdV-e1Sk3ytGF-WWu_0_1HXB1zjo |
CitedBy_id | crossref_primary_10_1007_s15010_024_02378_8 crossref_primary_10_3390_diagnostics14192125 crossref_primary_10_1111_myc_70043 crossref_primary_10_1002_smll_202400741 |
Cites_doi | 10.1080/21505594.2022.2054120 10.1080/21501203.2021.1994479 10.1016/j.cmi.2020.02.001 10.3389/fmicb.2020.01535 10.1007/s40121-022-00625-9 10.1128/JCM.00319-11 10.1111/myc.13471 10.1016/j.bioflm.2023.100126 10.1016/j.riam.2016.11.002 10.3201/eid2509.190040 10.1111/imj.14612 10.3390/biomedicines11041063 10.1111/myc.12790 10.1007/s10096-013-2027-1 10.1111/myc.12947 10.1186/s12879-023-08477-5 10.1080/22221751.2022.2100280 10.1016/j.jinf.2018.09.002 10.1016/S1473-3099(18)30597-8 10.1093/cid/ciac735 10.3201/eid2411.180368 10.1080/22221751.2021.1934557 10.1093/cid/ciw691 10.1111/myc.13626 10.1016/j.jcrc.2020.01.004 10.1128/JCM.02055-18 10.1016/j.ijid.2018.02.005 10.1111/myc.13396 10.1093/jac/dkx480 10.1007/978-1-4939-3052-4_14 10.1111/apm.13336 10.1016/j.eimc.2021.04.003 10.1038/s41426-018-0095-0 10.3390/microorganisms9040807 10.1093/mmy/myy054 10.3947/ic.2022.0008 10.1080/14787210.2023.2179036 10.1186/s12879-020-05543-0 10.1016/j.jiac.2023.03.018 10.1080/22221751.2022.2125349 10.1093/jac/dkx034 10.1016/j.jinf.2016.07.008 10.1016/j.ijid.2019.06.001 10.2147/IDR.S409708 10.3201/eid2509.190686 10.3201/eid2302.161320 10.1016/j.nmni.2016.07.003 10.1128/mSphere.00189-16 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2024 The Author(s) |
Copyright_xml | – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2024 The Author(s) |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1080/22221751.2023.2300525 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Geography |
DocumentTitleAlternate | EMERGING MICROBES & INFECTIONS |
EISSN | 2222-1751 |
ExternalDocumentID | oai_doaj_org_article_f9947f5851894873a4030e19d80cfd65 PMC10773663 38164742 10_1080_22221751_2023_2300525 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | 0YH 53G 5VS 7X7 88E 8FI 8FJ AAHBH AAYXX ABUWG ACGFS ADBBV ADRAZ AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BVXVI C6C CCPQU CITATION DIK EBS ECGQY EMOBN FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M1P M48 M4Z M~E NAO OK1 PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM TDBHL UKHRP BCNDV CGR CUY CVF ECM EIF EJD NPM PJZUB PPXIY 3V. 7XB 8FK AZQEC COVID DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c506t-2f710fe3b6f4e90e3bd8dc3b3e3cc938b20db378370c882e0313ef8d7a012b5b3 |
IEDL.DBID | 7X7 |
ISSN | 2222-1751 |
IngestDate | Wed Aug 27 01:14:49 EDT 2025 Thu Aug 21 18:42:08 EDT 2025 Fri Jul 11 12:24:42 EDT 2025 Fri Jul 25 09:13:47 EDT 2025 Mon Jul 21 05:56:13 EDT 2025 Tue Jul 01 03:24:00 EDT 2025 Thu Apr 24 23:13:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Candida auris candidemia whole-genome sequencing outcome resistance |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c506t-2f710fe3b6f4e90e3bd8dc3b3e3cc938b20db378370c882e0313ef8d7a012b5b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. Supplemental data for this article can be accessed https://doi.org/10.1080/22221751.2023.2300525. |
OpenAccessLink | https://www.proquest.com/docview/3142112363?pq-origsite=%requestingapplication% |
PMID | 38164742 |
PQID | 3142112363 |
PQPubID | 2041957 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f9947f5851894873a4030e19d80cfd65 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10773663 proquest_miscellaneous_2909090294 proquest_journals_3142112363 pubmed_primary_38164742 crossref_primary_10_1080_22221751_2023_2300525 crossref_citationtrail_10_1080_22221751_2023_2300525 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-Dec |
PublicationDateYYYYMMDD | 2024-12-01 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-Dec |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | Emerging microbes & infections |
PublicationTitleAlternate | Emerg Microbes Infect |
PublicationYear | 2024 |
Publisher | Taylor & Francis Ltd Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis Ltd – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_3_52_1 e_1_3_3_50_1 e_1_3_3_18_1 e_1_3_3_39_1 Salah H (e_1_3_3_17_1) 2021; 7 e_1_3_3_14_1 e_1_3_3_37_1 e_1_3_3_16_1 e_1_3_3_35_1 e_1_3_3_10_1 e_1_3_3_33_1 e_1_3_3_56_1 Gomez-Gaviria M (e_1_3_3_49_1) 2022; 9 e_1_3_3_12_1 e_1_3_3_31_1 e_1_3_3_54_1 e_1_3_3_40_1 AlJindan R (e_1_3_3_19_1) 2020; 7 e_1_3_3_7_1 e_1_3_3_9_1 e_1_3_3_29_1 e_1_3_3_25_1 e_1_3_3_48_1 e_1_3_3_27_1 e_1_3_3_46_1 e_1_3_3_3_1 e_1_3_3_21_1 e_1_3_3_44_1 e_1_3_3_5_1 e_1_3_3_23_1 e_1_3_3_30_1 e_1_3_3_51_1 Oladele R (e_1_3_3_42_1) 2022; 8 e_1_3_3_13_1 e_1_3_3_38_1 Ortiz-Roa C (e_1_3_3_34_1) 2023; 9 e_1_3_3_15_1 e_1_3_3_36_1 e_1_3_3_55_1 e_1_3_3_11_1 e_1_3_3_32_1 e_1_3_3_53_1 e_1_3_3_41_1 e_1_3_3_6_1 e_1_3_3_8_1 e_1_3_3_28_1 e_1_3_3_24_1 e_1_3_3_26_1 e_1_3_3_47_1 e_1_3_3_2_1 e_1_3_3_20_1 e_1_3_3_45_1 e_1_3_3_4_1 e_1_3_3_22_1 e_1_3_3_43_1 |
References_xml | – ident: e_1_3_3_13_1 doi: 10.1080/21505594.2022.2054120 – ident: e_1_3_3_38_1 doi: 10.1080/21501203.2021.1994479 – ident: e_1_3_3_2_1 – ident: e_1_3_3_35_1 doi: 10.1016/j.cmi.2020.02.001 – ident: e_1_3_3_48_1 doi: 10.3389/fmicb.2020.01535 – ident: e_1_3_3_36_1 doi: 10.1007/s40121-022-00625-9 – volume: 8 issue: 8 year: 2022 ident: e_1_3_3_42_1 article-title: Emergence and genomic characterization of multidrug resistant candida auris in Nigeria, West Africa publication-title: J Fungi (Basel) – ident: e_1_3_3_44_1 doi: 10.1128/JCM.00319-11 – ident: e_1_3_3_47_1 doi: 10.1111/myc.13471 – ident: e_1_3_3_55_1 doi: 10.1016/j.bioflm.2023.100126 – ident: e_1_3_3_27_1 doi: 10.1016/j.riam.2016.11.002 – ident: e_1_3_3_4_1 doi: 10.3201/eid2509.190040 – ident: e_1_3_3_6_1 doi: 10.1111/imj.14612 – ident: e_1_3_3_50_1 doi: 10.3390/biomedicines11041063 – ident: e_1_3_3_7_1 doi: 10.1111/myc.12790 – ident: e_1_3_3_32_1 doi: 10.1007/s10096-013-2027-1 – ident: e_1_3_3_56_1 doi: 10.1111/myc.12947 – ident: e_1_3_3_29_1 doi: 10.1186/s12879-023-08477-5 – ident: e_1_3_3_41_1 doi: 10.1080/22221751.2022.2100280 – ident: e_1_3_3_40_1 doi: 10.1016/j.jinf.2018.09.002 – ident: e_1_3_3_26_1 doi: 10.1016/S1473-3099(18)30597-8 – ident: e_1_3_3_30_1 doi: 10.1093/cid/ciac735 – ident: e_1_3_3_24_1 doi: 10.3201/eid2411.180368 – ident: e_1_3_3_53_1 doi: 10.1080/22221751.2021.1934557 – ident: e_1_3_3_11_1 doi: 10.1093/cid/ciw691 – ident: e_1_3_3_33_1 doi: 10.1111/myc.13626 – ident: e_1_3_3_8_1 doi: 10.1016/j.jcrc.2020.01.004 – ident: e_1_3_3_22_1 doi: 10.1128/JCM.02055-18 – ident: e_1_3_3_43_1 doi: 10.1016/j.ijid.2018.02.005 – ident: e_1_3_3_3_1 doi: 10.1111/myc.13396 – volume: 7 issue: 1 year: 2020 ident: e_1_3_3_19_1 article-title: Drug resistance-associated mutations in ERG11 of multidrug-resistant candida auris in a tertiary care hospital of eastern Saudi arabia publication-title: J Fungi (Basel) – ident: e_1_3_3_14_1 doi: 10.1093/jac/dkx480 – volume: 7 issue: 3 year: 2021 ident: e_1_3_3_17_1 article-title: Genomic epidemiology of candida auris in Qatar reveals hospital transmission dynamics and a South Asian origin publication-title: J Fungi (Basel) – ident: e_1_3_3_20_1 doi: 10.1007/978-1-4939-3052-4_14 – ident: e_1_3_3_51_1 doi: 10.1111/apm.13336 – ident: e_1_3_3_45_1 doi: 10.1016/j.eimc.2021.04.003 – ident: e_1_3_3_16_1 doi: 10.1038/s41426-018-0095-0 – volume: 9 issue: 1 year: 2022 ident: e_1_3_3_49_1 article-title: Non-albicans candida species: immune response, evasion mechanisms, and New plant-derived alternative therapies publication-title: J Fungi (Basel) – volume: 9 issue: 7 year: 2023 ident: e_1_3_3_34_1 article-title: Mortality caused by candida auris bloodstream infections in comparison with other candida species, a multicentre retrospective cohort publication-title: J Fungi (Basel) – ident: e_1_3_3_12_1 doi: 10.3390/microorganisms9040807 – ident: e_1_3_3_52_1 doi: 10.1093/mmy/myy054 – ident: e_1_3_3_9_1 doi: 10.3947/ic.2022.0008 – ident: e_1_3_3_18_1 – ident: e_1_3_3_54_1 doi: 10.1080/14787210.2023.2179036 – ident: e_1_3_3_5_1 doi: 10.1186/s12879-020-05543-0 – ident: e_1_3_3_46_1 doi: 10.1016/j.jiac.2023.03.018 – ident: e_1_3_3_15_1 doi: 10.1080/22221751.2022.2125349 – ident: e_1_3_3_37_1 doi: 10.1093/jac/dkx034 – ident: e_1_3_3_31_1 doi: 10.1016/j.jinf.2016.07.008 – ident: e_1_3_3_28_1 doi: 10.1016/j.ijid.2019.06.001 – ident: e_1_3_3_25_1 doi: 10.2147/IDR.S409708 – ident: e_1_3_3_10_1 doi: 10.3201/eid2509.190686 – ident: e_1_3_3_21_1 doi: 10.3201/eid2302.161320 – ident: e_1_3_3_39_1 doi: 10.1016/j.nmni.2016.07.003 – ident: e_1_3_3_23_1 doi: 10.1128/mSphere.00189-16 |
SSID | ssj0000706414 |
Score | 2.3624108 |
Snippet | is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of... Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we... Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2300525 |
SubjectTerms | Antifungal agents Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Biofilms Bioinformatics Candida Candida auris candidemia Candidemia - drug therapy Candidemia - epidemiology Candidemia - microbiology China - epidemiology Drug Resistance and Novel Antimicrobial Agents Drug Resistance, Fungal - genetics Genetic testing Genomes Geography Humans Infections Medical laboratories Microbial Sensitivity Tests Mutation outcome Pathogens Patients Phylogenetics resistance Whole genome sequencing |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhp0IJbdqmbpOgQo51YkvyQ721oUsoNKcEchN6pobGDt3NqX--M5Jt1iGQS_HFlh-SNSPPNx7pG0JOtLXcMOtyDcYqFwKHVGtZLr3j3opQcIMR3Z-X9cW1-HFT3Wyl-sI5YYkeOHXcWZBSNAGDV60EcM21ALX0pXRtYYOrI3sp2LwtZyp-gxswtaWYluy0xRnYQUDfFbqEjOP0Z0zgtjBGkbP_KaD5eL7klgFavSJ7I3KkX1OLX5Md3--Tl-m3G02rid6Qv6sO4BxNkQA6BHqOy1acpsgetKZdT0En-ls39Lefacyd_YVOiyMpXErvupmZKZbZJaEzPrKh_r5bD87HIxsr8HedfkuuV9-vzi_yMb9Cbqui3uQsALwInps6CC8L2HGtA9Fxz62VvDWscIY3SI9jAYh7pHn0oXWNBqtmKsPfkd1-6P17QuFDIQCb2NKU8KxamwqqKKUInJeVlnVGxNTRyo7k45gD47cqR47SST4K5aNG-WTkdL7tPrFvPHfDN5TifDGSZ8cCUCk1qpR6TqUycjjpgBpH9FrxUoCvzHjNM_JpPg1jEQMsuvfDw1oxWeDGpMjIQVKZuSUYoIUuYhlpF8q0aOryTN_9inzf4KE3HJDhh__xch_JC-gwkWbkHJLdzZ8HfwS4amOO4xD6B_ttGuQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9RAEB9qfVAQ0ao1WmUFH01NspuPFUS0eBShPnnQtyX7dQ20Sb27gsV_3plkE4xU5V7ukuxm2ZnZ-c3N7m8AXtfGcJ0ZG9forGIhyKQqk8XSWe6M8AnXlNE9-VocL8WX0_x0B0ZChTCBmxtDO6ontVyfH_74fv0BDf592CH3Fl0cAuucor2M085mqs12C26jcyrJVk8C4u8X5xJ9cCrGszx_az3zUj2Z_00I9M-NlL95psUDuB8gJfs46MBD2HHtHtwJ1c3Prvfg3vDfHBuOHD2Cn4sGMR8b0gWs8-yIzrbYmhHF0IY1LUPFaVe2a1dvWF9g-x0bT1AyfJRdNBN9U3_NzFmfqcuSuctm01nX_zL9C9xFUz-G5eLzt6PjOBRhiE2eFNs484hBvOO68MLJBL_YyqJ8uePGSF7pLLGal8ShYxCtO-KCdL6yZY2uT-eaP4HdtmvdU2C4mggEMCbVKfZV1DrHV6RSeM7TvJZFBGKcdGUCQzkVyjhXaSAyHWWlSFYqyCqCw6nZ5UDR8b8Gn0ii08PEsN1f6NYrFQxWeSlF6SlpWkkM6ngtcDl0qbRVYrwtsJODUR_UqLWKpwID6owXPIJX0200WMrC1K3rrjYqkwl9Miki2B_UZxoJZXFxirIIqplizYY6v9M2Zz0pOIbxJUf4-Ozf43oOd3EqxLAh5wB2t-sr9wJh1Va_7A3lF75XGr8 priority: 102 providerName: Scholars Portal |
Title | First report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38164742 https://www.proquest.com/docview/3142112363 https://www.proquest.com/docview/2909090294 https://pubmed.ncbi.nlm.nih.gov/PMC10773663 https://doaj.org/article/f9947f5851894873a4030e19d80cfd65 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9RAEB9s-6AgovUrWo8VfDQ2yW4-1hexpcchtIhYOJ9Csh_XgE2uzfWh-M87s9lET0QJHLl8bJadmZ3ZmdnfALyplOJ1onRYobIKhSCRKlQSSqO5UcJGvKaI7ulZtjgXn5bp0jvcep9WOc6JbqLWnSIf-SGPBa5VEp7xD-urkKpGUXTVl9DYgT2CLqOUrnyZTz4WZOdMxGLcuFNEh6gN0QZPaWGYcEqCpjJuWyrJIff_zdz8M2vyNzU0fwgPvP3IPg4EfwR3TLsPd30p84vbfbg_OOLYsL_oMfyYN2jgsSE2wDrLjmkji64Y4Qn1rGkZckm70l27estcNe33bNwuyfBRdtlMWE3umtqGeKYmc2bWTd9p4_4p9wFz2VRP4Hx-8vV4EfqKC6FKo2wTJhYNDmt4nVlhZIQnutBITG64UpIXdRLpmucEmKPQNDcE_GhsofMK9Vyd1vwp7LZda54Dw6lDoLWi4jrGtrKqTvETsRSW8zitZBaAGAe9VB6OnKpifC9jj1o60qokWpWeVgG8m15bD3gc_3vhiCg6PUxw2u5Cd70qvXSWVkqRW4qQFhJXcLwSOPeZWOoiUlZn2MjByA-ll_G-_MWRAbyebqN0Usilak1305eJjOhIpAjg2cA-U08oZItDlARQbDHWVle377TNhUMAxzV7ztFWfPHvfr2EezgUYsi-OYDdzfWNeYU21KaewU70bTFz4jKDvaOTs89fZs4fgb-novgJ4hAblA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7U7UMFEa231Koj6JuxyczkMoKIrV22tl1EWuhbTGYm20CbrM0WKf4nf6Pn5KYrok8lL7lOhjn3OTPfAXiRai0yro2borFypSSRijV3lTXCapl7IqOM7uE0nBzLjyfByQr86PfC0LLKXic2itpUmubIt4QvMVbhIhTv5l9dqhpF2dW-hEbLFvv26huGbPXbvQ9I35ecj3ePdiZuV1XA1YEXLlyeo1HNrcjCXFrl4YmJDXZYWKG1EnHGPZOJiEBhNLqflsANbR6bKEVdngWZwHZvwKoUGMqMYHV7d_rp8zCrgwIUSl_2W4VibwvtL3r9AYWiXNCyayoct2QEm1oBf3Nw_1yn-ZvhG9-B253Hyt63LHYXVmy5Dmtd8fTTq3W41U79sXZH0z34Pi7QpWRtNoJVOduhrTMmZYRgVLOiZMiX5cxU5ewVa-p3v2H9Bk2Gr7LzYkCHau7pZVBpajJidl7UlbHNlW5-YM-L9D4cXws1HsCorEr7CBgqK4n-kfYzH9sK0yzAX_hK5kL4QapCB2Q_6InuANCpDsdZ4nc4qT2tEqJV0tHKgdfDZ_MWAeR_H2wTRYeXCcC7uVFdzJJOHyS5UjLKKScbK4wZRSpR21pfmdjTuQmxkc2eH5JOq9TJLxlw4PnwGPUBJXnS0laXdcKVRwdX0oGHLfsMPaEkMQ4RdyBeYqylri4_KYvTBnPc96JIoHe68e9-PYO1ydHhQXKwN91_DDdxWGS79mcTRouLS_sEPbhF9rQTGwZfrltSfwIe4VXg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First+report+of+Candida+auris+in+Guangdong%2C+China%3A+clinical+and+microbiological+characteristics+of+7+episodes+of+candidemia&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Peng%2C+Yaqin&rft.au=Liu%2C+Yue&rft.au=Yu%2C+Xuegao&rft.au=Fang%2C+Jingchun&rft.date=2024-12-01&rft.pub=Taylor+%26+Francis+Ltd&rft.eissn=2222-1751&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1080%2F22221751.2023.2300525 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon |